spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Organogenesis 

 HSMN NewsFeed - 9 May 2022
Marengo Therapeutics Appoints Ke Liu, MD, PhD, and Bruce Chabner, MD, to Key Leadership Roles, Strengthening Marengo's Development Team and Supporting Translation to the Clinic
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Oct 2021
FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jan 2019
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Aug 2018
Eisai And Merck Announce FDA Approval Of LENVIMA(R) (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jun 2018
FDA Expands Lilly's ALIMTA(R) (pemetrexed) Label to Include Combination with KEYTRUDA(R) (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Apr 2018
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 15 Mar 2018
Organogenesis Announces New PuraPly(R) Antimicrobial Small Size
Devices Surgery Wound Care Product Launch
 HSMN NewsFeed - 26 Oct 2017
Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement
Devices Regenerative Medicine Wound Care Licensing
 HSMN NewsFeed - 12 Oct 2017
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Sep 2017
Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
Devices Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 26 Aug 2016
Advanced Wound Care Products PuraPly(TM) and PuraPly Antimicrobial(TM) Now Available for Medicare Reimbursement in 10 States
Devices Wound Care Reimbursement
 HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Jan 2014
Organogenesis Inc. Announces Acquisition of Dermagraft(R) from Shire
Devices Wound Care Acquisitions
 HSMN NewsFeed - 17 Jan 2014
Shire Executes Agreement to Divest DERMAGRAFT(R)
Devices Wound Care Acquisitions
 HSMN NewsFeed - 20 Dec 2013
Synta Announces Appointment of Steven Bernitz as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
Spectrum Pharmaceuticals Launches Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) and Ships First Commercial Orders
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 31 May 2013
Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Aug 2012
Atterocor Launches Innovative Company Focused on Accelerated Development of Treatment for Adrenal Cancer; Secures $16 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Apr 2012
Organogenesis Inc. Announces Major Milestones in Improved Apligraf(R) Reimbursement and Access to Care for Patients Suffering from Chronic Wounds
Devices Wound Care Reimbursement
 HSMN NewsFeed - 12 Mar 2012
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
Regenerative Medicine Wound Care FDA
 HSMN NewsFeed - 14 Jul 2011
HealOr Names Dr. Michael L. Sabolinski, M.D. as New CEO
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Oct 2010
Integra LifeSciences Features the Inforce(R) Reinforcement Matrix at the 65th Annual ASSH Meeting
Devices Orthopaedic
 HSMN NewsFeed - 26 May 2010
Organogenesis Announces Symposium for the Treatment of Chronic Wounds at EWMA Annual Conference in Switzerland
Regenerative Medicine Wound Care
 HSMN NewsFeed - 6 Oct 2008
Steven Bernitz Joins Concert Pharmaceuticals as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Feb 2008
Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2008
Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 11 Dec 2007
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
Devices Wound Care Regenerative Medicine
 HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Devices Interventional Cardiology Regenerative Medicine
 HSMN NewsFeed - 6 Mar 2007
Michael L. Sabolinski, M.D. Resigns from NitroMed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Nov 2006
HydroCision Promotes Steven Van Tyle to Vice President of Global Sales
Devices Personnel
 HSMN NewsFeed - 20 Sep 2006
Precision Optics Corporation Announces Additions to its Senior Management
Devices Personnel
Return to NewsFeed  

 Additional items found! 21

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 21 additional stories matching:
Organogenesis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.